DCL1 was initially identified as a gene missing or downregulated in primary hepatocellular carcinoma and exerts its carcinomatosis effects primarily utilizing the Rho-GTPase-activating protein (RhoGAP) structural domain [30–32]. This evidence concerns the gene STARD13 and hepatocellular carcinoma.